107 results
8-K
EX-10.1
ARQT
Arcutis Biotherapeutics Inc
10 Apr 24
Departure of Directors or Certain Officers
4:15pm
, written or oral, which is not contained in this agreement for the purpose of inducing you to execute the agreement, and you acknowledge that you
8-K
ARQT
Arcutis Biotherapeutics Inc
10 Apr 24
Departure of Directors or Certain Officers
4:15pm
October 2020 to November 2022 at Frazier Life Sciences Acquisition Corp., a special purpose acquisition company, and as Chief Financial Officer
8-K
EX-1.1
ARQT
Arcutis Biotherapeutics Inc
4 Mar 24
Other Events
4:10pm
for
that purpose or pursuant to Section 8A of the Act has been initiated or threatened by the Commission (the base prospectus filed as part of the Initial … for any such purpose, including pursuant to Section 8A under the Act, or of any request by the Commission for the amending or supplementing
424B5
ARQT
Arcutis Biotherapeutics Inc
1 Mar 24
Prospectus supplement for primary offering
4:06pm
the original recipient, and may not be reproduced or used for any other purpose. The interests in the securities may not be offered or sold directly … ; or
(ii)a trust (where the trustee is not an accredited investor) whose sole purpose is to hold investments and each beneficiary of the trust
424B5
fv2yk556s1 ytv
28 Feb 24
Prospectus supplement for primary offering
4:21pm
S-8
53rtqjpud 3i
27 Feb 24
Registration of securities for employees
4:34pm
S-8
zgn4adb04vhg574
27 Feb 24
Registration of securities for employees
4:34pm
424B5
b0i0jmf7
8 Feb 24
Prospectus supplement for primary offering
4:31pm
S-3
EX-4.5
o5cj9cg
31 Jan 24
Shelf registration
5:22pm
S-3
9hkha
31 Jan 24
Shelf registration
5:22pm
S-3
EX-1.2
622pl1n3satsg lt7l
31 Jan 24
Shelf registration
5:22pm
SC TO-I
jtse2
16 Jan 24
Issuer tender offer statement
6:03am
SC TO-I
EX-99
52h dlsjao60vendh4r4
16 Jan 24
Issuer tender offer statement
6:03am
SC TO-I
EX-99
98jxh6wdl mh
16 Jan 24
Issuer tender offer statement
6:03am
SC TO-I
daqqe ritq9pf0eyf30
16 Jan 24
Issuer tender offer statement
6:03am